3 Australian growth stocks to buy in 2026

Let's see which stocks are being tipped as buys for the year ahead.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Growth investing is about backing businesses that dominate their niches, generate strong returns on capital, and still have room to expand.

But which Australian growth stocks tick these boxes?

Listed below are three that analysts are bullish on and are tipping as buys:

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.

Image source: Getty Images

Light & Wonder Inc. (ASX: LNW)

The first Australian growth stock to consider in 2026 is Light & Wonder.

This is not just a gaming machine manufacturer. It is a content company operating across land-based casinos, online real money gaming, and social gaming platforms.

The real strength of Light & Wonder lies in intellectual property. Successful game franchises can be rolled out across physical cabinets, digital channels, and new markets. That multiplies the lifetime value of each piece of content.

As gaming continues shifting toward digital channels and hybrid models, Light & Wonder is positioned across multiple touchpoints rather than relying on a single revenue stream. That diversification gives it more levers to pull over time.

Bell Potter currently rates Light & Wonder shares as a buy with a price target of $220.00.

Pro Medicus Ltd (ASX: PME)

Another Australian growth stock worth serious consideration is Pro Medicus.

Pro Medicus provides imaging software to hospitals and healthcare providers. Its Visage platform allows medical professionals to view and analyse complex imaging data quickly and efficiently.

Healthcare systems do not replace core software lightly. Once embedded, switching costs are high and contracts are often long term.

The company continues to win large hospital networks, expanding its footprint in the US market. With healthcare demand rising and digital imaging volumes growing, Pro Medicus is benefiting from structural tailwinds rather than cyclical ones.

Morgans is a big fan and has a buy rating and $275.00 price target on Pro Medicus' shares.

REA Group Ltd (ASX: REA)

A final Australian growth stock to consider in 2026 is REA Group.

REA is best known for operating Australia's leading online property platform. But the real story is its ecosystem.

The company has built a marketplace that connects buyers, sellers, agents, and increasingly data-driven services around property transactions. Premium listings, data insights, and digital tools give REA multiple revenue streams tied to property activity.

Even though property markets can fluctuate year to year, the long-term shift toward digital advertising and data services remains firmly in place. REA's dominant position gives it pricing power that smaller competitors struggle to match.

The team at UBS is bullish and has a buy rating and $218.90 price target on REA Group's shares.

Motley Fool contributor James Mickleboro has positions in Pro Medicus and REA Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Light & Wonder Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Light & Wonder Inc and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Purple tech growth chart.
Growth Shares

2 wonderful ASX All Ords stocks I'd buy today

These stocks could deliver great returns. Here’s why…

Read more »

Cheerful man in a orange shirt standing in front of an audience holding a tablet and using hand gestures to interact with the audience.
Growth Shares

3 amazing ASX growth shares that continue to stand out

Looking for growth options? Here are three to consider.

Read more »

Person pointing finger on on an increasing graph which represents a rising share price.
Growth Shares

2 ASX shares tipped to grow at least 50% in the next 12 months

These stocks could be some of the best ones to own today.

Read more »

Scared looking people on a rollercoaster ride representing volatility.
Growth Shares

What's driving the wild swings in Telix shares?

The ASX biotech stock offers high-growth potential, but it comes with volatility.

Read more »

An executive in a suit smooths his hair and laughs as he looks at his laptop feeling surprised and delighted.
Growth Shares

3 stellar ASX growth shares to buy now with 30% to 70% upside

Analysts have buy ratings and lofty price targets on these shares.

Read more »

Person using a calculator with four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX shares that I rate as buys today for both growth and dividends!

These businesses have plenty going for them. I’m calling them buys…

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Share Market News

NextDC shares rocket 27% higher: Buy, hold or sell?

Can NextDC shares keep climbing higher, or have they now peaked?

Read more »

A woman on a green background points a finger at graphic images of molecules, a rocket, light bulbs, and scientific symbols as she smiles.
Growth Shares

3 exciting ASX shares you won't want to miss out on

These ASX shares are not just growing. They are expanding into much larger opportunities.

Read more »